Table 4.

The table shows that an expression of PPARγ in the cytoplasm from IRS values of 2 upwards is a survival disadvantage in disease-free survival. The tumor patients with IRS values of 2 and above live disease-free for a median of 129 months; Patients with lower IRS values, however, live 192 months and thus much longer. Overall the patients live 163 months. The difference between both IRS groups (from 2 or below) is a disease-free survival difference of 63 months, i.e., more than 5 years.

Medians for Disease-Free Survival Time (Months)
PPARγ IRS Value in Cytoplasm	Estimate	Lower 95% Confidence Interval	Upper 95% Confidence Interval
IRS < 2	192.000	127.692	256.308
IRS ≥ 2	129.000	20.907	237.093
Overall	163.000	203.332	203.332